Barrio-Hernandez, Inigo https://orcid.org/0000-0002-5686-0451
Schwartzentruber, Jeremy
Shrivastava, Anjali
del-Toro, Noemi
Gonzalez, Asier
Zhang, Qian
Mountjoy, Edward
Suveges, Daniel
Ochoa, David https://orcid.org/0000-0003-1857-278X
Ghoussaini, Maya https://orcid.org/0000-0002-2415-2143
Bradley, Glyn
Hermjakob, Henning https://orcid.org/0000-0001-8479-0262
Orchard, Sandra https://orcid.org/0000-0002-8878-3972
Dunham, Ian https://orcid.org/0000-0003-2525-5598
Anderson, Carl A.
Porras, Pablo
Beltrao, Pedro https://orcid.org/0000-0002-2724-7703
Article History
Received: 19 July 2021
Accepted: 30 January 2023
First Online: 23 February 2023
Competing interests
: C.A.A. has received consultancy fees from Genomics PLC and BridgeBio Inc. G.B. is an employee of GSK. The remaining authors declare no competing interests.